Thanks for the response. I thought not. With that being the case, if HJOE has cleared foreign standards, and I don't know that they have, the argument that the FDA will play their hand and regulate the recovery shot as a new drug is moot. If HJOE were to sell the drug nationally as opposed to a foreign country, perhaps the FDA would play a bigger role. As far as my understanding goes, HJOE is exporting the shot.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.